lifETIME Academic wins national 2020 TechWomen100 Award

By lifETIME CDT Administrator: Emma Lardner (University of Birmingham) Dr. Pola Goldberg Oppenheimer, Royal Academy of Engineering Fellow at the University of Birmingham, lifETIME supervisor and Chair of our Interdisciplinary Skills Committee has won a TechWomen100 Award which celebrates the success of future female tech leaders. Dr. Oppenheimer has demonstrated a great success in her work on

From a 3D perspective: AML and the bone marrow niche

By LifETIME CDT Student: Lauren Hope (University of Glasgow)   Acute myeloid leukaemia (AML) is a malignancy of the blood, caused by a build-up of genetic mutations, which can lead to a lack of mature blood cells in the bloodstream. Current AML research includes the use of small animal models and 2D cell culture systems. Whilst

2020 Cohort Training Programme

By lifETIME CDT Administrator: Emma Lardner (University of Birmingham) Since the COVID-19 pandemic hit the UK earlier this year, we have worked hard to adapt the lifETIME programme to be delivered online. Our 2019 cohort were fortunate enough to be able to have in-person rotational training which created an environment to network with other cohort members,

My Angle on Glaucoma

By LifETIME CDT Student: Hannah Lamont (University of Birmingham) Going into my PhD project, I knew little about glaucoma and how exactly it’s become the leading cause of irreversible blindness worldwide. Now, a year  into my project and I’m completely fascinated by this disease and where exactly the crux of the problem lies; in two

LifETIME CDT Student Day

By LifETIME CDT Administrator: Emma Lardner (University of Birmingham) Delegates have attended the first virtual LifETIME CDT Student Day event bringing together academics, industry partners and LifETIME students. The event began with a welcome from Ivan Wall, Professor of Regenerative Medicine, Cell & Gene Therapy Bioprocessing at Aston University who gave an informative overview of the

FLIM starring metastatic pancreatic cancer cells

By LifETIME CDT Student: Elena Mandrou (University of Glasgow) My project revolves around studying a signalling pathway that previous research showed it is important for the directional metastasis (or spread) of aggressive cancers.  The signal in question is a lipid called lysophosphatidic acid (or LPA) that exists in the cells’ surroundings. The cells’ have a

1 10 11 12 13 14 16